Alliancebernstein L.P. Decreases Holdings in The Cooper Companies, Inc. $COO

Key Points

• Alliancebernstein L.P. has reduced its stake in The Cooper Companies by 14.3%, selling 647,270 shares and now owning 3,882,720 shares valued at approximately $327.5 million.
• Several institutional investors have also modified their holdings in Cooper Companies, with notable new purchases from Zions Bancorporation, City Holding Co., and GKV Capital Management during the first quarter.
• Cooper Companies recently reported an earnings per share (EPS) of $1.10 for the quarter, exceeding analysts' expectations, alongside a year-over-year revenue increase of 5.7%.

Alliancebernstein L.P. lowered its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 14.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 3,882,720 shares of the medical device company's stock after selling 647,270 shares during the period. Alliancebernstein L.P. owned about 1.94% of Cooper Companies worth $327,507,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Zions Bancorporation National Association UT bought a new position in Cooper Companies during the 1st quarter worth $33,000. City Holding Co. acquired a new stake in shares of Cooper Companies in the first quarter valued at about $34,000. GKV Capital Management Co. Inc. acquired a new stake in shares of Cooper Companies in the first quarter valued at about $40,000. Larson Financial Group LLC raised its position in shares of Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after acquiring an additional 664 shares during the last quarter. Finally, HM Payson & Co. lifted its position in shares of Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the period. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of COO stock traded down $1.02 during trading hours on Tuesday, reaching $67.77. The stock had a trading volume of 646,283 shares, compared to its average volume of 2,292,793. The stock's fifty day simple moving average is $71.94 and its 200 day simple moving average is $76.43. The firm has a market capitalization of $13.47 billion, a PE ratio of 33.39, a PEG ratio of 1.72 and a beta of 0.97. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $112.38. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of research firms have issued reports on COO. Loop Capital set a $100.00 price target on Cooper Companies in a report on Tuesday, June 17th. JPMorgan Chase & Co. decreased their price target on Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a research report on Thursday, August 28th. Robert W. Baird lowered their price objective on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating on the stock in a research report on Thursday, August 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $94.00 price target on shares of Cooper Companies in a research report on Thursday, August 28th. Finally, Morgan Stanley set a $76.00 target price on shares of Cooper Companies and gave the stock an "equal weight" rating in a research report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and an average price target of $86.64.

Insider Activity at Cooper Companies

In other news, COO Gerard H. Warner III bought 1,450 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The shares were acquired at an average price of $69.23 per share, with a total value of $100,383.50. Following the completion of the purchase, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. The trade was a 8.60% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Brian G. Andrews purchased 1,525 shares of the stock in a transaction on Tuesday, September 2nd. The shares were purchased at an average price of $65.68 per share, for a total transaction of $100,162.00. Following the transaction, the executive vice president directly owned 22,191 shares of the company's stock, valued at approximately $1,457,504.88. This represents a 7.38% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 15,975 shares of company stock worth $1,079,566 over the last quarter. 1.98% of the stock is currently owned by corporate insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.